|
UBE2Z expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.544100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.606830E-01 |
| Normal-vs-Stage2 |
4.390800E-01 |
| Normal-vs-Stage3 |
3.834100E-02 |
| Normal-vs-Stage4 |
6.639500E-03 |
| Stage1-vs-Stage2 |
9.085000E-01 |
| Stage1-vs-Stage3 |
3.188000E-01 |
| Stage1-vs-Stage4 |
6.100200E-02 |
| Stage2-vs-Stage3 |
4.378600E-01 |
| Stage2-vs-Stage4 |
1.870450E-01 |
| Stage3-vs-Stage4 |
4.251200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.331620E-01 |
| Normal-vs-AfricanAmerican |
8.561400E-01 |
| Normal-vs-Asian |
2.357200E-01 |
| Caucasian-vs-AfricanAmerican |
5.010800E-01 |
| Caucasian-vs-Asian |
8.409600E-01 |
| AfricanAmerican-vs-Asian |
4.408000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.245570E-02 |
| Normal-vs-Female |
1.426820E-01 |
| Male-vs-Female |
1.105190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.042800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.506200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.484000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.444800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.806040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.331900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.486000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.599400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.575200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.006200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.573000E-01 |
| Classical-VS-Follicular |
1.396370E-04 |
| Classical-VS-Other |
3.267800E-02 |
| Classical-VS-Normal |
6.022400E-01 |
| Tall-VS-Follicular |
1.028050E-01 |
| Tall-VS-Other |
1.602250E-01 |
| Tall-VS-Normal |
3.683600E-01 |
| Follicular-VS-Other |
5.823600E-01 |
| Follicular-VS-Normal |
4.249500E-04 |
| Other-VS-Normal |
1.162020E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.712400E-02 |
| Normal-vs-N1 |
4.020400E-03 |
| N0-vs-N1 |
9.499700E-02 |
|
|
